Artificial intelligence (AI) is rapidly emerging as a transformative technology in the pharmaceutical and biomedical fields. This narrative review article focuses on the emerging role of artificial intelligence (AI) in the paradigm shift of pharmaceutical and biomedical sciences. The current article discusses the potential of AI to revolutionise the pharmaceutical industry by increasing the efficiency and effectiveness of drug development and discovery, lowering drug development costs and providing personalised medicine. Furthermore, the article emphasises the potential of AI in disease prevention and outbreak prediction by analysing large data sets and identifying patterns and trends that can aid in the development of targeted interventions. Furthermore, the article discusses the importance of AI in biomedical research, particularly in genomics, proteomics and metabolomics. Finally, the article discusses the potential of AI in transforming the patient-physician interface by improving diagnosis and treatment accuracy and efficiency. Overall, this review article provides an overview of the current state of the art in artificial intelligence (AI) in pharmaceutical and biomedical sciences, highlighting the potential for future development and impact on patient care.
Loading....